This Blue Chip Bargain Stock Is a Strong Buy for Growth Investors
Becoming a successful investor doesn't require a crystal ball: All you need is a viable theme for your investment thesis and a long-term investing mindset. More times than not with these two attributes, your investments will turn out to be profitable over the long run.
A mounting disease burden and a growing elderly population are just two of the numerous factors that could be growth catalysts in the long haul for the health insurance industry. This is why the market research company named Precedence Research expects that the global health insurance market will compound at 6.8% annually from $2.2 trillion in 2022 to reach almost $3.8 trillion by 2030.
Centene (NYSE: CNC) could emerge as one of the biggest winners from these trends that are favorable to health insurers. Here's why.
Source Fool.com
